No Data
No Data
No Data
No Data
No Data
Independent Director of Design Therapeutics Picks Up 88% More Stock
Yahoo FinanceMar 27 06:15 ET
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders int
BenzingaMar 26 07:37 ET
Design Therapeutics(DSGN.US) Director Buys US$99,738.48 in Common Stocks
$Design Therapeutics(DSGN.US)$ Director Schmid John P. purchased 26,965 shares of Common Stocks on Mar 22, 25, 2024 at an average price of $3.6988 for a total value of $99,738.48.Source: Announcement
moomoo NewsMar 25 19:53 ET
Design Therapeutics(DSGN.US) Director Buys US$4,865.77 in Common Stocks
$Design Therapeutics(DSGN.US)$ Director Berger Heather A. purchased 1,300 shares of Common Stocks on Mar 25, 2024 at an average price of $3.7429 for a total value of $4,865.77.Source: Announcement Wha
moomoo NewsMar 25 19:48 ET
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring reve
Simply Wall StMar 23 08:03 ET
Hold Rating Maintained for Design Therapeutics Amid Drug Reformulation and Program Updates
TipRanksMar 21 02:18 ET
No Data
No Data